Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on March 2, 2005
J Am Soc Nephrol 16: 1126-1134, 2005
© 2005 American Society of Nephrology
doi: 10.1681/ASN.2004070530

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2004070530v1
16/4/1126    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Han, W. K.
Right arrow Articles by Bonventre, J. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Han, W. K.
Right arrow Articles by Bonventre, J. V.

Clinical Immunology and Pathology

Human Kidney Injury Molecule-1 Is a Tissue and Urinary Tumor Marker of Renal Cell Carcinoma

Won K. Han*,{ddagger},**, Anwar Alinani*, Chin-Lee Wu§,{dagger}{dagger}, Dror Michaelson||,**, Massimo Loda{dagger},{dagger}{dagger},§§, Francis J. McGovern,{ddagger}{ddagger}, Ravi Thadhani{ddagger},** and Joseph V. Bonventre*,{ddagger},**

* Renal; {dagger} Pathology Divisions, Brigham and Women’s Hospital; {ddagger} Medical; § Pathology; || Oncology; Urology Services, Massachusetts General Hospital; and Departments of; ** Medicine,; {dagger}{dagger} Pathology; {ddagger}{ddagger} Urology, Harvard Medical School; and § Pathology Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts

Address correspondence to: Dr. Joseph V. Bonventre, Harvard Institutes of Medicine, 4 Blackfan Circle, Renal Division, Room 550, Boston, MA 02115. Phone: 617-525-5969; Fax: 617-525-5965; joseph_bonventre{at}hms.harvard.edu

Received for publication July 6, 2004. Accepted for publication January 17, 2005.

Human kidney injury molecule-1 (hKIM-1) is a type 1 transmembrane protein that is not detectable in normal kidney tissue but is expressed at high levels in human and rodent kidneys with dedifferentiated proximal tubule epithelial cells after ischemic or toxic injury. Therefore, it was hypothesized that renal tumors express hKIM-1 and release this protein into the urine. Forty renal cell carcinoma (RCC) and 484 nonrenal tumors were analyzed by immunohistochemistry for expression of hKIM-1 (group 1). Urine samples before nephrectomy and nephrectomy tissue samples were collected from an additional 42 patients with renal tumors, from 30 normal control subjects, and also from 10 patients with prostate carcinoma (group 2). In five additional patients with RCC, urine was collected before and after nephrectomy (group 3). Tissue was examined for expression of hKIM-1, and cell-free urine supernatants were analyzed for hKIM-1 by ELISA. Urinary hKIM-1 was normalized to the urinary creatinine concentration (UCr). Expression of hKIM-1 was present in 32 tissue sections (91%) of 35 clear cell RCC (group 1). In group 2, the normalized urinary hKIM-1 levels were significantly higher in patients with clear cell RCC (0.39 ± 0.08 ng/mg UCr; n = 21), compared with levels in patients with prostate carcinoma (0.12 ± 0.03 ng/mg UCr; P < 0.02; n = 10), or normal control subjects (0.05 ± 0.01 ng/mg UCr; P < 0.005; n = 30). Tissue sections from 28 (82%) of 34 primary RCC stained positively for the expression of hKIM-1. In all patients with a detectable prenephrectomy urinary hKIM-1 level, there was either complete disappearance or marked reduction after nephrectomy (group 3). In conclusion, the cleaved ectodomain of hKIM-1 can be detected in the urine of patients with RCC and may serve as a new biomarker for early detection of RCC.




This article has been cited by other articles:


Home page
Toxicol SciHome page
Y. Zhou, V. S. Vaidya, R. P. Brown, J. Zhang, B. A. Rosenzweig, K. L. Thompson, T. J. Miller, J. V. Bonventre, and P. L. Goering
Comparison of Kidney Injury Molecule-1 and Other Nephrotoxicity Biomarkers in Urine and Kidney Following Acute Exposure to Gentamicin, Mercury, and Chromium
Toxicol. Sci., January 1, 2008; 101(1): 159 - 170.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
Z. Zhang, B. D. Humphreys, and J. V. Bonventre
Shedding of the Urinary Biomarker Kidney Injury Molecule-1 (KIM-1) Is Regulated by MAP Kinases and Juxtamembrane Region
J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2704 - 2714.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
O. Liangos, M. C. Perianayagam, V. S. Vaidya, W. K. Han, R. Wald, H. Tighiouart, R. W. MacKinnon, L. Li, V. S. Balakrishnan, B. J.G. Pereira, et al.
Urinary N-Acetyl-beta-(D)-Glucosaminidase Activity and Kidney Injury Molecule-1 Level Are Associated with Adverse Outcomes in Acute Renal Failure
J. Am. Soc. Nephrol., March 1, 2007; 18(3): 904 - 912.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. Perez-Rojas, J. A. Blanco, C. Cruz, J. Trujillo, V. S. Vaidya, N. Uribe, J. V. Bonventre, G. Gamba, and N. A. Bobadilla
Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity
Am J Physiol Renal Physiol, January 1, 2007; 292(1): F131 - F139.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. H. de Borst, M. M. van Timmeren, V. S. Vaidya, R. A. de Boer, M. B. A. van Dalen, A. B. Kramer, T. A. Schuurs, J. V. Bonventre, G. Navis, and H. van Goor
Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase
Am J Physiol Renal Physiol, January 1, 2007; 292(1): F313 - F320.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. M. van Timmeren, S. J. L. Bakker, V. S. Vaidya, V. Bailly, T. A. Schuurs, J. Damman, C. A. Stegeman, J. V. Bonventre, and H. van Goor
Tubular kidney injury molecule-1 in protein-overload nephropathy
Am J Physiol Renal Physiol, August 1, 2006; 291(2): F456 - F464.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. Mesri, G. Smithson, A. Ghatpande, A. Chapoval, S. Shenoy, F. Boldog, C. Hackett, C. E. Pena, C. Burgess, A. Bendele, et al.
Inhibition of in vitro and in vivo T cell responses by recombinant human Tim-1 extracellular domain proteins
Int. Immunol., March 1, 2006; 18(3): 473 - 484.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
V. S. Vaidya, V. Ramirez, T. Ichimura, N. A. Bobadilla, and J. V. Bonventre
Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury
Am J Physiol Renal Physiol, February 1, 2006; 290(2): F517 - F529.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP